Le Lézard
Classified in: Health, Science and technology, Covid-19 virus

Novel Microdevices Joins Baltimore's LaunchPorttm Medtech Venture Center

BALTIMORE, Feb. 26, 2021 /PRNewswire-PRWeb/ -- The LaunchPorttm announced today that Novel Microdevices (http://www.noveldx.com) has moved to their Medtech venture center in Port Covington, Baltimore, and has established The LaunchPorttm as its primary location for their GMP development efforts.

Novel Microdevices has established engineering prototyping, clean room operations, materials handling, and shop capabilities in separate modules within the Center that are allowing them to develop and validate the various elements of their Good Manufacturing Processes (GMP). The Company has received over $2M in NIH funding and is in the process of securing additional contracts for the delivery of diagnostics of sexually transmitted infections. The Company also recently received funding from NIH's RADx program to explore the possible application of their technology to COVID-19 diagnostics.

Robert Storey, Managing Partner of The LaunchPorttm, noted that cofounders Andrea and Rohan Pais have steadily built their company from a concept over the past six years in Baltimore, drawing on significant clinical support from the institutions in the area. The Pais' both started their careers with SB Microsystems (Glen Burnie, MD) an anchor of biomedical sensor development in the Baltimore area. "This is a power team and we're pleased that that Micro is joining us at this exciting time in their journey. We have every expectation that they will become an important element for the growth of diagnostics manufacturing in the region".

About Novel Microdevices (Baltimore, MD)
Novel Microdevices is commercializing Novel Dx, a proprietary and best-in-class Point-of-Care (POC) rapid molecular diagnostics system that is designed to be CLIA-waived. The Novel Dx system includes an ultra-portable instrument and test-specific consumable cartridges that can be produced for a wide range of high-volume molecular diagnostic assay applications. The company is focusing on the $31 Billion Infectious Diseases Diagnostics Market with tests in development for multiple respiratory and sexually transmitted infections.

About The LaunchPorttm (Port Covington, Baltimore, MD)
The LaunchPorttm (http://www.thelaunchport.com) is a Medtech venture center that allows Medtech start-ups and emerging technology developers the ability to co-locate at an experienced, regulated manufacturing center. Located at the "City Garage" in Baltimore's Port Covington, it is in close proximity to two of the Country's premier medical schools (Johns Hopkins and University of Maryland) and at the center of one of the world's largest urban revitalization projects.

Media Contact

Robert Storey, The LaunchPort, +1 (443) 994-2241, bstorey@mvrco.com


SOURCE The LaunchPort

These press releases may also interest you

at 11:05
BioCurity, a private preclinical biotech, is developing oncology supportive care drugs that are designed to prevent or mitigate some of the side effects associated with radiation therapy. Today, BioCurity announced it has filed a US provisional...

at 11:00
The "Smart Baby Monitor Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Video Monitor Device and Audio Monitor Device), Sales Channel (Online and Offline), and Application (Home/Family, Hospitals, and Day Care), Geography"...

at 11:00
The urology surgery supplies market is poised to grow by $ 750.29 mn during 2021-2025, progressing at a CAGR of over 4% during the forecast period.  Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and...

at 11:00
The "Global Virtual Clinical Trials Market By Study Type, By Indication, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering. The Global Virtual Clinical Trials Market size is expected...

at 11:00
The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show: 1,217 new cases, bringing the total number of people infected 340,397; 317,338 people have recovered; 6 new deaths, but the total of deaths amounts to 10,838,...

at 11:00
Results of a newly released Long Island University Steven S. Hornstein Center for Policy, Polling and Analysis national poll reveal that half of Americans believe the recovering economy is a result of the federal government's COVID-19 stimulus aid...

News published on 26 february 2021 at 23:00 and distributed by: